Literature DB >> 18161637

Preparation, rheological study, and characterization of an organogel as a system for transdermal release of active principles.

M A Ruiz1, B Clares, M E Morales, V Gallardo.   

Abstract

The use of formulations containing Pluronic gel as a vehicle and permeabilizing agent for transdermal preparations has increased in recent years. We prepared and compared two transdermal formulations for drug administration as an alternative to oral or parenteral administration. In formulations containing Pluronic F127 gel or pluronic lecithin organogel (PLO), rheological, structural (transmission electron microscopy) and physicochemical characteristics were studied under different conditions of composition, temperature, and time from 24 hr to 3 months after preparation. Rheological studies at 20-25 degrees C and at 4 degrees C to study the influence of refrigeration on viscosity and pH showed that both formulas were thermoreversible. Unilamellar vesicles smaller than 1 microm in diameter were seen in the PLO formulation on TEM observation. The characteristics of these excipients may facilitate the application and may avoid the gastrointestinal tract and the first-pass effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18161637     DOI: 10.1080/10837450701247400

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  2 in total

1.  Supramolecular gels from sugar-linked triazole amphiphiles for drug entrapment and release for topical application.

Authors:  Komal Sharma; Jojo P Joseph; Adarsh Sahu; Narender Yadav; Mohit Tyagi; Ashmeet Singh; Asish Pal; K P Ravindranathan Kartha
Journal:  RSC Adv       Date:  2019-06-27       Impact factor: 4.036

2.  Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.

Authors:  Chia-En Chang; Chien-Ming Hsieh; Ling-Chun Chen; Chia-Yu Su; Der-Zen Liu; Hua-Jing Jhan; Hsiu-O Ho; Ming-Thau Sheu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.